Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
07.03. | NewGenIVF Group Limited: NewGenIvf Provides Update on Proposed Reverse Merger with European Wellness Holdings and Completion of Strategic Acquisition of MicroSort Reproductive Technology | 163 | GlobeNewswire (Europe) | BANGKOK, March 08, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals... ► Artikel lesen | |
07.03. | NewGenIvf Group Ltd - F-1, Registration statement for certain foreign private issuers | - | SEC Filings | ||
03.03. | NewGenIVF Group Limited: NewGen and BOBCARE Announce Strategic Collaboration to Expand Fertility Services in Kyrgyzstan | 624 | GlobeNewswire (Europe) | BANGKOK, March 03, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals... ► Artikel lesen | |
28.02. | NewGenIvf erfüllt wieder Nasdaq-Anforderungen und wechselt Börsenplatz | 1 | Investing.com Deutsch | ||
28.02. | NewGenIvf regains Nasdaq compliance, transfers markets | 1 | Investing.com | ||
28.02. | NewGenIVF Group Limited: NewGen Regains Compliance with Nasdaq Minimum Bid Price Requirement and Announces Listing Transfer to the Nasdaq Capital Market | 123 | GlobeNewswire (Europe) | BANGKOK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain... ► Artikel lesen | |
20.02. | NewGenIVF Group Limited: NewGen Issues Clarification on Press Release Titled "NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director" dated February 20, 2025 | 3 | GlobeNewswire (USA) | ||
NEWGENIVF GROUP Aktie jetzt für 0€ handeln | |||||
20.02. | Pre-market Movers: WORK Medical Technology, Xos, Inc., NewGenIvf Group, Herbalife, PodcastOne | 497 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.15 A.M. ET).In the Green WORK Medical Technology Group LTD (WOK) is up over... ► Artikel lesen | |
20.02. | NewGenIvf Group receives approval for continued Nasdaq listing; shares rise | 3 | Seeking Alpha | ||
20.02. | NewGenIvf Says Granted Request For Continued Listing On Nasdaq | 2 | RTTNews | ||
20.02. | NewGenIVF Group Limited: NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director | 158 | GlobeNewswire (Europe) | Company Granted Request to Continue its Listing on NasdaqAppoints Thorain Ko to Lead Business Development Initiatives BANGKOK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF)... ► Artikel lesen | |
20.02. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
19.02. | Pre-market Movers: Sintx Technologies, Cycurion, OSR Holdings, ReShape Lifesciences, NewGenIvf Group | 483 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.35 A.M. ET).In the Green Sintx Technologies, Inc. (SINT) is up over 87%... ► Artikel lesen | |
31.01. | NewGenIvf to execute reverse stock split | 2 | Seeking Alpha | ||
31.01. | NewGenIVF Group Limited: NewGen Announces Reverse Stock Split | 174 | GlobeNewswire (Europe) | BANGKOK, Jan. 31, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain... ► Artikel lesen | |
31.01. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
21.01. | NewGenIVF Group Limited: NewGen Announces Strategic Acquisition of MicroSort Reproductive Technology | 148 | GlobeNewswire (Europe) | The technology, which will be acquired for US$5 million, allows for the separation of X and Y chromosome-bearing sperm cells MicroSort offers several advantages for those seeking reproductive assistance... ► Artikel lesen | |
21.01. | NewGenIvf Group Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
13.01. | NewGenIVF Group Limited: NewGen Launches Innovative Lifetime Egg Freezing Service to Address Growing Market Need in Asia | 4 | GlobeNewswire (USA) | ||
23.12.24 | NewGenIVF Group Limited: NewGen Progresses Reverse Merger Plans with Engagement of Legal Teams and Updated Timeline | 374 | GlobeNewswire (Europe) | BANGKOK, Dec. 23, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) ("NewGen" or the "Company") today announced that both parties involved in the previously announced reverse merger... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SERNOVA BIOTHERAPEUTICS | 0,113 | +2,54 % | Sernova Aktie: Positives Umsatzwachstum gemeldet! | Das Biotechnologieunternehmen erweitert sein Führungsteam, sichert Finanzierungen und erhält FDA-Freigabe für klinische Studien zur Behandlung von Hypothyreose. Sernova Biotherapeutics, ehemals Sernova... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,627 | -4,42 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Announces Plans to Pursue Metastatic Breast Cancer Indication for (Z)-Endoxifen and Continued Engagement with FDA on Additional Indications | SEATTLE, March 11, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment... ► Artikel lesen | |
PING AN HEALTHCARE | 0,908 | +0,87 % | Ping An Healthcare and Technology Company Limited: Ping An Health Reports First Full-Year Profit in 2024 | Synergies Between Health Care and Insurance Drive Scalable GrowthAI Innovations Fuel Continued Success
SHANGHAI and HONG KONG, March 13, 2025 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
MOUNTAIN VALLEY MD | 0,008 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
CO-DIAGNOSTICS | 0,422 | +6,03 % | Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance | The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component
SALT LAKE CITY, Feb. 21, 2025 /PRNewswire/... ► Artikel lesen | |
CYTOSORBENTS | 0,990 | -5,71 % | CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue | Fourth quarter product revenue growth estimated at 22% to 25% year-over-year Fourth quarter gross margin estimated to improve to approximately 70% Management will host in-person investor... ► Artikel lesen | |
VERU | 0,428 | -3,30 % | Veru Aktie: Glänzende Aussichten steigern Hoffnung! | Der Biopharmahersteller Veru befindet sich aktuell in einer positiven Entwicklungsphase. Anfang März 2025 zeigt die Aktie deutliche Anzeichen einer Erholung vom 52-Wochen-Tief von 0,49 US-Dollar. Mit... ► Artikel lesen | |
TEMPEST THERAPEUTICS | 0,765 | -0,84 % | Tempest Therapeutics: FDA Study May Proceed Notice Received for Phase 2 Trial of TPST-1495 for the Treatment of Familial Adenomatous Polyposis (FAP) | BRISBANE, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
VOLITIONRX | 0,552 | 0,00 % | VolitionRx erweitert Krebstest-Vereinbarung mit Fujifilm Vet Systems | ||
EKSO BIONICS | 0,406 | +2,53 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Fourth Quarter and Full-Year 2024 Financial Results | SAN RAFAEL, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
IMUNON | 0,780 | +0,65 % | Imunon, Inc.: IMUNON Reports 2024 Financial Results and Provides Business Update Highlighting Significant Progress Towards the Initiation of a Pivotal Phase 3 Study | IMNN-001 remains the first immunotherapy to achieve a meaningful overall survival benefit in advanced ovarian cancer Patient enrollment in Phase 3 pivotal trial of IMNN-001 scheduled to begin in... ► Artikel lesen | |
BEYOND AIR | 0,246 | -0,81 % | Beyond Air, Inc. - 8-K, Current Report | ||
AVINGER | 0,340 | -6,08 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
NOVACYT | 0,574 | -3,20 % | Novacyt S.A. - Liquidity Agreement and Total Voting Rights | ||
AROVELLA THERAPEUTICS | 0,053 | 0,00 % | XFRA E4NA: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen |